Overview

Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin

Status:
Not yet recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess and compare the effectiveness of levofloxacin-tetracycline -containing and metronidazole-tetracycline-containing quadruple regimens for the primary treatment of Helicobacter pylori infection in patients allergic to penicillin.
Phase:
Phase 4
Details
Lead Sponsor:
Shandong University
Treatments:
Levofloxacin
Metronidazole
Ofloxacin